Ken Kono

603 total citations
29 papers, 494 citations indexed

About

Ken Kono is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Ken Kono has authored 29 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 8 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Ken Kono's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (8 papers) and Immune Cell Function and Interaction (7 papers). Ken Kono is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (8 papers) and Immune Cell Function and Interaction (7 papers). Ken Kono collaborates with scholars based in Japan, United States and Germany. Ken Kono's co-authors include Tatsuo Shioda, Kristen M. Drescher, Steven Tracy, Emi E. Nakayama, Shubhada Bopegamage, Steven D. Carson, Masaru Yokoyama, Hironori Sato, Rumi Sawada and Hirofumi Akari and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Ken Kono

29 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Kono Japan 12 213 165 163 138 103 29 494
Anne‐Laure Favier France 14 208 1.0× 68 0.4× 109 0.7× 118 0.9× 212 2.1× 37 496
Jes Kuruvilla United States 8 97 0.5× 106 0.6× 102 0.6× 91 0.7× 281 2.7× 9 513
Kai Cui China 14 187 0.9× 92 0.6× 73 0.4× 210 1.5× 67 0.7× 32 557
Efrat Kochba United States 15 26 0.1× 244 1.5× 80 0.5× 66 0.5× 183 1.8× 20 701
P. Li Australia 10 233 1.1× 176 1.1× 182 1.1× 47 0.3× 102 1.0× 21 525
Christoph G. Ammann Austria 16 338 1.6× 382 2.3× 161 1.0× 41 0.3× 116 1.1× 31 719
Birgitte Rønde Hansen Denmark 14 59 0.3× 33 0.2× 146 0.9× 39 0.3× 36 0.3× 39 484
Kapil Saharia United States 11 24 0.1× 74 0.4× 171 1.0× 144 1.0× 113 1.1× 27 735
Tsugumine Shu Japan 12 91 0.4× 154 0.9× 130 0.8× 55 0.4× 113 1.1× 28 347
Pinyi Du United States 11 160 0.8× 134 0.8× 98 0.6× 21 0.2× 141 1.4× 13 433

Countries citing papers authored by Ken Kono

Since Specialization
Citations

This map shows the geographic impact of Ken Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Kono more than expected).

Fields of papers citing papers by Ken Kono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Kono. The network helps show where Ken Kono may publish in the future.

Co-authorship network of co-authors of Ken Kono

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Kono. A scholar is included among the top collaborators of Ken Kono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Kono. Ken Kono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kono, Ken, Rumi Sawada, Takuya Kuroda, et al.. (2021). A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells. Scientific Reports. 11(1). 11407–11407. 2 indexed citations
3.
Kono, Ken, et al.. (2020). A highly sensitive method for the detection of recombinant PERV-A/C env RNA using next generation sequencing technologies. Scientific Reports. 10(1). 21935–21935. 7 indexed citations
4.
Kono, Ken, Rumi Sawada, Takuya Kuroda, et al.. (2019). Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells. Scientific Reports. 9(1). 3630–3630. 7 indexed citations
5.
7.
Kono, Ken, Shingo Kobayashi, Yoji Sato, et al.. (2016). In Vitro Endothelialization Test of Biomaterials Using Immortalized Endothelial Cells. PLoS ONE. 11(6). e0158289–e0158289. 5 indexed citations
8.
Takeda, Eri, Ken Kono, Amy E. Hulme, et al.. (2015). Fluorescent Image Analysis of HIV-1 and HIV-2 Uncoating Kinetics in the Presence of Old World Monkey TRIM5α. PLoS ONE. 10(3). e0121199–e0121199. 7 indexed citations
9.
Kono, Ken, Nozomi Takada, Satoshi Yasuda, et al.. (2014). Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells. Biologicals. 43(2). 146–149. 18 indexed citations
10.
Kono, Ken, Eri Takeda, Amy E. Hulme, et al.. (2013). Slower Uncoating Is Associated with Impaired Replicative Capability of Simian-Tropic HIV-1. PLoS ONE. 8(8). e72531–e72531. 6 indexed citations
11.
Nomaguchi, Masako, Masaru Yokoyama, Ken Kono, et al.. (2012). Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells. Microbes and Infection. 15(1). 56–65. 23 indexed citations
12.
Miyamoto, Tadashi, Emi E. Nakayama, Masaru Yokoyama, et al.. (2012). The Carboxyl-Terminus of Human Immunodeficiency Virus Type 2 Circulating Recombinant form 01_AB Capsid Protein Affects Sensitivity to Human TRIM5α. PLoS ONE. 7(10). e47757–e47757. 6 indexed citations
13.
Bożek, Katarzyna, Emi E. Nakayama, Ken Kono, & Tatsuo Shioda. (2012). Electrostatic Potential of Human Immunodeficiency Virus Type 2 and Rhesus Macaque Simian Immunodeficiency Virus Capsid Proteins. Frontiers in Microbiology. 3. 206–206. 4 indexed citations
14.
Saito, Akatsuki, Ken Kono, Masako Nomaguchi, et al.. (2011). Geographical, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomolgus macaque (Macaca fascicularis). Journal of General Virology. 93(3). 594–602. 20 indexed citations
15.
Saito, Akatsuki, Masako Nomaguchi, Sayuki Iijima, et al.. (2010). Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes and Infection. 13(1). 58–64. 33 indexed citations
16.
Kono, Ken, Haihan Song, Masaru Yokoyama, et al.. (2010). Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction. Retrovirology. 7(1). 72–72. 22 indexed citations
17.
Kono, Ken, Katarzyna Bożek, Francisco S. Domingues, Tatsuo Shioda, & Emi E. Nakayama. (2009). Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5α SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity. Virology. 388(1). 160–168. 11 indexed citations
19.
Nakayama, Emi E., et al.. (2008). TRIM5α-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells. Virology. 375(2). 514–520. 7 indexed citations
20.
Drescher, Kristen M., Ken Kono, Shubhada Bopegamage, Steven D. Carson, & Steven Tracy. (2004). Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology. 329(2). 381–394. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026